跳至主要内容
临床试验/NCT04550533
NCT04550533Unknown不适用

DESIGN AND VALIDATION OF A SCALE TO EVALUATE THERAPEUTIC ADHERENCE IN PATIENTS WITH ANTINEOPLASTIC DRUGS

Universidad Miguel Hernandez de Elche0 个研究点目标入组 288 人开始时间: 2021年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
288
主要终点
Measure of therapeutic adherence

研究概览

简要总结

Introduction: In recent years, there has been an increase in the use of oral chemotherapy, for its comfort and for allowing a higher quality of life. However, one of the main drawbacks is the lack of adherence to treatment with important clinical, social and economic consequences. In this scenario, the investigators did not have a questionnaire designed and validated to measure adherence in onco-hematological patients, a population that was erroneously considered very adherent.

The objective of the investigators is to build and validate a questionnaire to measure adherence to treatment in oncohematological patients in treatment with oral anti-cancer drugs.

Methods and analysis: An observational study to validate questionnaires will be carried out combining qualitative and quantitative research techniques. With the results of a systematic review of the literature and a qualitative study based on focus groups, a questionnaire will be designed to measure adherence in oncohematological patients in treatment with with oral anti-cancer drugs. The investigators will include patiens from two hospitals in the Valencian Community.

Discussion: It is essential to have a simple, reliable and validated instrument for measuring adherence in cancer patients undergoing treatment with oral antineoplastic agents. With this, lack of therapeutic compliance and its causes can be detected in order to establish interventions that improve it.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over the age of 18 in treatment with oral anti-cancer drugs (groups L01 and L02 according to the ATC drug classification), that come to the San Juan Hospital or Elda General Hospital to collect their medication, will be included.

排除标准

  • Those patients with communication difficulties, and/or do not agree to take part in the study, will be excluded

结局指标

主要结局

Measure of therapeutic adherence

时间窗: At least 3 month after treatment

To build and validate a questionnaire to measure adherence to treatment in oncohematological patients in treatment with oral antineoplastic drugs

次要结局

  • Barriers and difficulties in evaluating adherence(At least 3 month after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elsa López Pintor

Dr

Universidad Miguel Hernandez de Elche

相似试验

DESIGN OF A SCALE TO MEASURE COMPLIANCE WITH DRUG... | 临床试验